Sign in
4

Changes in Ownership

Unicycive Therapeutics, Inc. Filed Acc 0001213900-25-080808

Director acquired 652,900 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Aggarwal Gaurav · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-25 Conversion : show line 1 in the form +652,900 1,789,915 I

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-25 Returned to the company : show line 2 in the form Series A-2 Prime Preferred Stock −3,199.21 $1,000.00 $3,199,210 0 I
Loading xslF345X05/ownership.xml…